Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at lenalidomide for B cell chronic lymphocytic leukaemia (CLL 009)

Overview

Cancer types:

Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial looked at lenalidomide for B cell chronic lymphocytic leukaemia (CLL) that had come back or not responded to treatment.

The trial was open for people to join between 2010 and 2012. The team reported the results in 2016.

Recruitment start: 10 January 2010

Recruitment end: 11 September 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Hillmen

Supported by

Celgene Corporation

Experimental Cancer Medicine Centre (ECMC)

Last reviewed: 10 September 2018

CRUK internal database number: 5889

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.